Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Autor: Shah, Bijal, Ghobadi, Armin, Oluwole, Olalekan, Logan, Aaron, Boissel, Nicolas, Cassaday, Ryan, Leguay, Thibaut, Bishop, Michael, Topp, Max, Tzachanis, Dimitrios, O'Dwyer, Kristen, Arellano, Martha, Lin, Yi, Baer, Maria, Schiller, Gary, Park, Jae, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique, Wierda, William, Deangelo, Daniel, Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra, Faghmous, Imi, Masouleh, Behzad Kharabi, Houot, Roch

Publikováno v: 64th ASH Annual Meeting and Exposition
64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.3158-3161, ⟨10.1182/blood-2022-158248⟩

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd363fd029ca7015f12ed0a029af10c2
https://doi.org/10.1182/blood-2022-158248

Additional file 1 of Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Autor: Shah, Bijal D., Ghobadi, Armin, Oluwole, Olalekan O., Logan, Aaron C., Boissel, Nicolas, Cassaday, Ryan D., Leguay, Thibaut, Bishop, Michael R., Topp, Max S., Tzachanis, Dimitrios, O’Dwyer, Kristen M., Arellano, Martha L., Lin, Yi, Baer, Maria R., Schiller, Gary J., Park, Jae H., Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C., Wierda, William G., DeAngelo, Daniel J., Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra C., Faghmous, Imi, Masouleh, Behzad Kharabi, Houot, Roch

Additional file 1. Supplementary Appendix.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d44b96a8cf2e75a5a69e3b51deaca80

O13-4 2-year update of KTE-X19 in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3

Autor: Shah, Bijal D., Ghobadi, Armin, Oluwole, Olalekan O., Logan, Aaron C., Boissel, Nicolas, Cassaday, Ryan D., Forcade, Edouard, Bishop, Michael R., Topp, Max S., Tzachanis, Dimitrios, O'Dwyer, Kristen M., Arellano, Martha L., Lin, Yi, Baer, Maria R., Schiller, Gary J., Zhou, Lang, Schuberth, Petra C., Masouleh, Behzad Kharabi, Houot, Roch

Publikováno v: In Annals of Oncology November 2023 34 Supplement 3:S1389-S1389

9 - Subgroup Analyses of Kte-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Adult Patients (Pts) with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in Zuma-3

Autor: Shah, Bijal D., Cassaday, Ryan D., Park, Jae H., Houot, Roch, Oluwole, Olalekan O., Logan, Aaron C., Boissel, Nicolas, Leguay, Thibaut, Bishop, Michael R., Topp, Max S., Tzachanis, Dimitrios, O’Dwyer, Kristen M., Arellano, Martha L., Lin, Yi, Baer, Maria R., Schiller, Gary J., Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C., Wierda, William G., DeAngelo, Daniel J., Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra C., Masouleh, Behzad Kharabi, Ghobadi, Armin

Publikováno v: In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S7-S8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.